{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:34:48Z","timestamp":1791070488446,"version":"4.1.0"},"reference-count":33,"publisher":"Japanese Pharmacological Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2007]]},"DOI":"10.1254\/jphs.fp0071287","type":"journal-article","created":{"date-parts":[[2007,12,20]],"date-time":"2007-12-20T05:50:34Z","timestamp":1198129834000},"page":"353-360","source":"Crossref","is-referenced-by-count":63,"title":["Negative Relationship Between Morphine Analgesia and P-Glycoprotein Expression Levels in the Brain"],"prefix":"10.1254","volume":"105","author":[{"given":"Wakako","family":"Hamabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norikazu","family":"Kiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chizuko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Tokuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiroh","family":"Kishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.14.7744"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Ishikawa T, Hirano H, Onishi Y, Sakurai A, Tarui S. Functional evaluation of ABCB1 (P-glycoprotein) polymorphisms: high-speed screening and structure&ndash;activity relationship analyses. Drug Metab Pharmacokinet. 2004;9:1&ndash;14.","DOI":"10.2133\/dmpk.19.1"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.7.3048"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Klepstad P, Dale O, Skorpen F, Borchgrevink PC, Kaasa S. Genetic variability and clinical efficacy of morphine. Acta Anaesthesiol Scand. 2005;49:902&ndash;908.","DOI":"10.1111\/j.1399-6576.2005.00772.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Ohtsuki S, Hori S, Terasaki T. [Molecular mechanisms of drug influx and efflux transport at the blood-brain barrier]. Folia Pharmacol Jpn. (Nippon Yakurigaku Zasshi). 2003;122:55&ndash;64. (text in Japanese with English abstract)","DOI":"10.1254\/fpj.122.55"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Tunblad K, Ederoth P, Gardenfors A, Hammarlund-Udenaes M, Nordstrom CH. Altered brain exposure of morphine in experimental meningitis studied with microdialysis. Acta Anaesthesiol Scand. 2004;48:294&ndash;301.","DOI":"10.1111\/j.0001-5172.2003.0311.x"},{"key":"7","unstructured":"7 Tsuji A, Sakata A, Tamai I. [Tissue distribution of the multidrug-resistance gene product P-glycoprotein and its physiological function]. Nippon Rinsho. 1997;55:1059&ndash;1063. (text in Japanese with English abstract)"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Kerb R. Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Lett. 2006;234:4&ndash;33.","DOI":"10.1016\/j.canlet.2005.06.051"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FP0040832"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.39.1.361"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Hamabe W, Maeda T, Fukazawa Y, Kumamoto K, Shang LQ, Yamamoto A, et al. P-glycoprotein ATPase activating effect of opioid analgesics and their P-glycoprotein-dependent antinociception in mice. Pharmacol Biochem Behav. 2006;85:629&ndash;636.","DOI":"10.1016\/j.pbb.2006.10.018"},{"issue":"3","key":"12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0022-3565(24)29643-9","volume":"297","author":"TANABE M","year":"2001","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Meineke I, Freudenthaler S, Hofmann U, Schaeffeler E, Mikus G, Schwab M, et al. Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine. Br J Clin Pharmacol. 2002;54:592&ndash;603.","DOI":"10.1046\/j.1365-2125.2002.t01-1-01689.x"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000019412.87412.BC"},{"issue":"3","key":"15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1254\/jjp.16.287","volume":"16","author":"TAKAGI HIROSHI","year":"1966","ISSN":"https:\/\/id.crossref.org\/issn\/0021-5198","issn-type":"print"},{"issue":"6","key":"16","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/j.1471-4159.1991.tb06433.x","volume":"57","year":"1991","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3042","issn-type":"print"},{"issue":"3","key":"17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1042\/bj2760745","volume":"276","year":"1991","ISSN":"https:\/\/id.crossref.org\/issn\/0264-6021","issn-type":"print"},{"key":"18","unstructured":"18 He L, Liu GQ. Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier. Acta Pharmacol Sin. 2002;23:423&ndash;429."},{"issue":"2","key":"19","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1432-1033.1997.00664.x","volume":"244","year":"1997","ISSN":"https:\/\/id.crossref.org\/issn\/0014-2956","issn-type":"print"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1080\/07420520600650745"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Weed MR, Hienz RD. Effects of morphine on circadian rhythms of motor activity and body temperature in pig-tailed macaques. Pharmacol Biochem Behav. 2006;84:487&ndash;496.","DOI":"10.1016\/j.pbb.2006.06.012"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M308175200"},{"issue":"3","key":"23","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0022-3565(24)38281-3","volume":"289","author":"KEST B","year":"1999","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.047902"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Kalinichev M, White DA, Holtzman SG. Individual differences in locomotor reactivity to a novel environment and sensitivity to opioid drugs in the rat. I. Expression of morphine-induced locomotor sensitization. Psychopharmacology (Berl). 2004;177:61&ndash;67.","DOI":"10.1007\/s00213-004-1990-8"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 White DA, Kalinichev M, Holtzman SG. Individual differences in locomotor reactivity to a novel environment and sensitivity to opioid drugs in the rat. II. Agonist-induced antinociception and antagonist-induced suppression of fluid consumption. Psychopharmacology (Berl). 2004;177:68&ndash;78.","DOI":"10.1007\/s00213-004-1921-8"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Macintyre PE, Jarvis DA. Age is the best predictor of postoperative morphine requirements. Pain. 1996;64:357&ndash;364.","DOI":"10.1016\/0304-3959(95)00128-X"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Thirlwell MP, Sloan PA, Maroun JA, Boos GJ, Besner JG, Stewart JH, et al. Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients. Cancer. 1989;63:2275&ndash;2283.","DOI":"10.1002\/1097-0142(19890601)63:11<2275::AID-CNCR2820631136>3.0.CO;2-4"},{"issue":"1","key":"29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00007691-199101000-00001","volume":"13","year":"1991","ISSN":"https:\/\/id.crossref.org\/issn\/0163-4356","issn-type":"print"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology. 1991;74:53&ndash;63.","DOI":"10.1097\/00000542-199101000-00010"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Collin E, Poulain P, Gauvain-Piquard A, Petit G, Pichard-Leandri E. Is disease progression the major factor in morphine &lsquo;tolerance&rsquo; in cancer pain treatment? Pain. 1993;55:319&ndash;326.","DOI":"10.1016\/0304-3959(93)90007-C"},{"issue":"2","key":"32","first-page":"532","volume":"276","year":"1996","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Bouw R, Ederoth P, Lundberg J, Ungerstedt U, Nordstrom CH, Hammarlund-Udenaes M. Increased blood-brain barrier permeability of morphine in a patient with severe brain lesions as determined by microdialysis. Acta Anaesthesiol Scand. 2001;45:390&ndash;392.","DOI":"10.1034\/j.1399-6576.2001.045003390.x"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T07:32:12Z","timestamp":1737703932000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/105\/4\/105_FP0071287\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.fp0071287","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007]]}}}